U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
ANCROD
EL55307L15
Possibly Marketed Outside US
General
Record Details
Names
15
Classification
5
Identifiers
12
Subunits
1
Disulfide Links
6
Glycosylation
5
Relationships
1
Characteristic Attributes
3
ANCROD
EL55307L15
Possibly Marketed Outside US
General
Approval Year
Unknown
Record Details
Substance Class
Protein
Protein Sub Type
Record UNII
EL55307L15
Record Status
Validated (UNII)
Record Version
10
9
8
7
6
5
4
3
2
1
Names
15
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
ANCROD
Official Name
English
ANCROD [USAN]
Common Name
English
VENOMBIN-A
Common Name
English
ANCROD [MART.]
Common Name
English
ARWIN
Common Name
English
Showing 1 to 5 of 15 entries
Previous
1
2
3
Next
Classification
5
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
To establish and maintain anticoagulation in heparin-intolerant patients undergoing cardiopulmonary bypass.
FDA ORPHAN DRUG
37189
Enzymes
ATC
BLOOD AND BLOOD FORMING ORGANS
ANTITHROMBOTIC AGENTS
ANTITHROMBOTIC AGENTS
Enzymes
ancrod
WHO-ATC
B01AD09
Enzymes
VATC
ANTITHROMBOTIC AGENTS
ANTITHROMBOTIC AGENTS
Enzymes
ancrod
WHO-VATC
QB01AD09
Agent Affecting Blood or Body Fluid
Pharmacologic Substance
[C1909]
Agent Affecting Blood or Body Fluid
[C78275]
Anticoagulant Agent
NCI_THESAURUS
C263
Agent Affecting Blood or Body Fluid
Pharmacologic Substance
[C1909]
Agent Affecting Blood or Body Fluid
[C78275]
Thrombolytic Agent
NCI_THESAURUS
C29750
Showing 1 to 5 of 5 entries
Previous
1
Next
Identifiers
12
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
ECHA (EC/EINECS)
232-933-6
PRIMARY
DRUG BANK
DB05099
PRIMARY
INN
2886
PRIMARY
NCI_THESAURUS
C95255
PRIMARY
FDA UNII
EL55307L15
PRIMARY
Showing 1 to 5 of 12 entries
Previous
1
2
3
Next
Subunits
1
Subunit 0
>SUBUNIT_0
Disulfide Links
6
Show
5
20
100
All
entries
From
To
From
To
1_7
1_141
1_28
1_44
1_78
1_232
1_120
1_188
1_152
1_167
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Glycosylation
5
Show
5
20
100
All
entries
Glycosylation Link Type
Site
Glycosylation Link Type
Site
N
1_23
N
1_79
N
1_99
N
1_148
N
1_229
Showing 1 to 5 of 5 entries
Previous
1
Next
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
6D53G0FD0Z
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
Interaction Type:
BINDING
Amount:
95 % (average)
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
3
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
MOL_WEIGHT:NUMBER(CALCULATED)
CHEMICAL
ESTIMATED 26600 Da (average)
Molecular Formula
CHEMICAL
ESTIMATED
C1156H1796N350O336S18
Biological Half-life
PHARMACOKINETIC
[3 to 5] hours (average)
